Onconova Therapeutics, Inc. (ONTX) earnings
Quarterly and annual ONTX reports and results, each read against the price at its own news timestamp. Back to the ONTX overview →
6 measured ONTX earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Traws Pharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-K/A Traws Pharma, Inc. For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-K Onconova Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -3.45% | -0.47% | |
| Form 10-Q Onconova Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -5.82% | |
| Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Results | Press release | +0.00% | -5.82% | |
| Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2023 Financial Results on November 14, 2023 | Press release | +0.00% | +2.33% |
Keep exploring
More ONTX: analyst actions → · SEC filings → · ONTX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| REVIVE THERAPEUTICS LTD (RVVTF) | 51 | +1.42% | 58% |
| Ventripoint Diagnostics Ltd (VPT_CDNX) | 51 | -1.92% | 39% |
| PATIENT PORTAL TECHS INC (PPRG) | 50 | 0.00% | 11% |
| STRAUMANN HOLDING AG (SAUHF) | 50 | +0.01% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.